Author:
Rojas Luis Alfonso,Condezo Gabriela N.,Moreno Rafael,Fajardo Carlos Alberto,Arias-Badia Marcel,San Martín Carmen,Alemany Ramon
Funder
IDIBELL
Ministerio de Economía y Competitividad
Reference49 articles.
1. Oncolytic viruses: a new class of immunotherapy drugs;Kaufman;Nat. Rev. Drug Discov.,2015
2. Oncolytic adenovirus: strategies and insights for vector design and immuno-oncolytic applications;Uusi-Kerttula;Viruses,2015
3. Merck Ad5/HIV induces broad innate immune activation that predicts CD8(+) T-cell responses but is attenuated by preexisting Ad5 immunity;Zak;Proc. Natl. Acad. Sci. U. S. A.,2012
4. International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations;Barouch;Vaccine,2011
5. International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials;Mast;Vaccine,2010
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献